Cargando…

Clinical perspectives with long-term pulsed inhaled nitric oxide for the treatment of pulmonary arterial hypertension

Pulmonary arterial hypertension (PAH) is a chronic, progressive disease of the pulmonary vasculature with a high morbidity and mortality. Its pathobiology involves at least three interacting pathways – prostacyclin (PGI(2)), endothelin, and nitric oxide (NO). Current treatments target these three pa...

Descripción completa

Detalles Bibliográficos
Autores principales:	Barst, Robyn J., Channick, Richard, Ivy, Dunbar, Goldstein, Brahm
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Medknow Publications & Media Pvt Ltd 2012
Materias:	Review Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3401867/ https://www.ncbi.nlm.nih.gov/pubmed/22837854 http://dx.doi.org/10.4103/2045-8932.97589

Ejemplares similares

A review of pulmonary arterial hypertension: role of ambrisentan
por: Barst, Robyn J
Publicado: (2007)

Pulmonary vascular effects of pulsed inhaled nitric oxide in COPD patients with pulmonary hypertension
por: Hajian, Bita, et al.
Publicado: (2016)

Vasoreactivity to inhaled nitric oxide with oxygen predicts long-term survival in pulmonary arterial hypertension
por: Malhotra, Rajeev, et al.
Publicado: (2011)

Association between inhaled nitric oxide treatment and long-term pulmonary function in survivors of acute respiratory distress syndrome
por: Dellinger, R Phillip, et al.
Publicado: (2012)

Short‐Term Effects of Inhaled Nitric Oxide on Right Ventricular Flow Hemodynamics by 4‐Dimensional–Flow Magnetic Resonance Imaging in Children With Pulmonary Arterial Hypertension
por: Schäfer, Michal, et al.
Publicado: (2021)

An electrochemical nitric oxide generator for in-home inhalation therapy in pulmonary artery hypertension
por: Liu, Yiwei, et al.
Publicado: (2022)

Novel use of riociguat in infants with severe pulmonary arterial hypertension unable to wean from inhaled nitric oxide
por: Domingo, L. T., et al.
Publicado: (2022)

Pulmonary hypertension: Past, present and future
por: Barst, Robyn J.
Publicado: (2008)

Effects of inhaled nitric oxide on hemostasis in healthy adults treated with heparin: a randomized, controlled, blinded crossover study
por: Goldstein, Brahm, et al.
Publicado: (2012)

Nitric oxide and pulmonary arterial hypertension
por: Chester, Adrian H., et al.
Publicado: (2017)

Comparison of intravenous sildenafil with inhaled nitric oxide for acute vasodilator testing in pulmonary arterial hypertension
por: Kumar, Shine, et al.
Publicado: (2022)

Clinical response to inhaled nitric oxide in persistent pulmonary hypertension of the newborn.
por: Ko, S. Y., et al.
Publicado: (1998)

Inhaled Nitric Oxide before Induction of Anesthesia in Patients with Pulmonary Hypertension
por: Eljezi, Vedat, et al.
Publicado: (2021)

Comparison of acute hemodynamic effects of inhaled nitric oxide and inhaled epoprostenol in patients with pulmonary hypertension
por: Preston, Ioana R., et al.
Publicado: (2013)

Clinical trials in neonates and children: Report of the pulmonary hypertension academic research consortium pediatric advisory committee
por: Adatia, Ian, et al.
Publicado: (2013)

Rapid Transition from Inhaled Iloprost to Inhaled Treprostinil in Patients with Pulmonary Arterial Hypertension
por: Bourge, Robert C, et al.
Publicado: (2013)

Classification of pediatric pulmonary hypertensive vascular disease: Does it need to be different from the adult classification?
por: Barst, Robyn J.
Publicado: (2011)

Pregnancy in pulmonary arterial hypertension
por: Olsson, Karen M., et al.
Publicado: (2016)

A Comparative Study of Inhaled Nitric Oxide and an Intravenously Administered Nitric Oxide Donor in Acute Pulmonary Hypertension
por: Stene Hurtsén, Anna, et al.
Publicado: (2020)

Outpatient Inhaled Nitric Oxide in a Patient with Vasoreactive Idiopathic Pulmonary Arterial Hypertension and COVID-19 Infection
por: Zamanian, Roham T., et al.
Publicado: (2020)

Inhaled nitric oxide in postpneumonectomy pulmonary edema
por: Keegan, MT, et al.
Publicado: (2003)

Diagnosis, Evaluation and Treatment of Pulmonary Arterial Hypertension in Children
por: Frank, Benjamin S., et al.
Publicado: (2018)

Pharmacokinetic and clinical profile of a novel formulation of bosentan in children with pulmonary arterial hypertension: the FUTURE-1 study
por: Beghetti, Maurice, et al.
Publicado: (2009)

Inhaled Nitric Oxide Counterbalances ET-1 Dependent Pulmonary Hypertension and Bronchoconstriction in the Pig
por: Clement, M. G., et al.
Publicado: (1994)

Inhaled nitric oxide in persistent pulmonary hypertension of the newborn refractory to high-frequency ventilation
por: Al-Alaiyan, Saleh, et al.
Publicado: (1999)

Nitric oxide and pulmonary hypertension
por: Sim, Ji-Yeon
Publicado: (2010)

Therapy for Pulmonary Arterial Hypertension: Glance on Nitric Oxide Pathway
por: Tettey, Abraham, et al.
Publicado: (2021)

Implication of inhaled nitric oxide for the treatment of critically ill COVID‐19 patients with pulmonary hypertension
por: Feng, Wen‐Xia, et al.
Publicado: (2020)

Magnetic resonance phase contrast imaging in children with pulmonary artery hypertension
por: Fonseca, Brian, et al.
Publicado: (2009)

Safety and tolerability of macitentan in the management of pulmonary arterial hypertension: an update
por: Wong, Alexandra K, et al.
Publicado: (2019)

Inhaled treprostinil and pulmonary arterial hypertension
por: Nadler, Samuel T, et al.
Publicado: (2010)

Inhaled nitric oxide for neonates with persistent pulmonary hypertension of the newborn in the CINRGI study: time to treatment response
por: Nelin, Leif D., et al.
Publicado: (2019)

Inhaled nitric oxide testing in predicting prognosis in pulmonary hypertension due to left‐sided heart diseases
por: Satoh, Taijyu, et al.
Publicado: (2023)

Is the inhaled nitric oxide useful in pulmonary embolism? An experimental study
por: Aldecoa, C, et al.
Publicado: (2003)

Emerging Pathogenetic Mechanisms of Pulmonary Arterial Hypertension: Nitric Oxide and More
por: Kim, Young Dae
Publicado: (2011)

Evaluation of the effect of nitric oxide inhalation in the patients with chronic thromboembolic pulmonary hypertension or pulmonary disease during balloon pulmonary angioplasty
por: Saito, Shota, et al.
Publicado: (2022)

Endotoxin-induced pulmonary hyporesponsiveness to inhaled nitric oxide is improved by nitric oxide synthase 2 inhibition
por: Bopp, C, et al.
Publicado: (2000)

Inhaled and exhaled nitric oxide
por: Thébaud, B., et al.
Publicado: (1999)

Variability in uptake efficiency for pulsed versus constant concentration delivery of inhaled nitric oxide
por: Martin, Andrew R, et al.
Publicado: (2014)

In vitro validation and characterization of pulsed inhaled nitric oxide administration during early inspiration
por: Pickerodt, Philipp A., et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_hkadlmbaih5gt7qa535fja45f4